A Pennsylvania woman is the latest cancer patient to file a permanent alopecia lawsuit, adding to the ever-growing pile of litigation against Sanofi over its chemotherapy drug’s side effects.

After being diagnosed with cancer, the plaintiff, Linda W., began treatment with the chemotherapy drug Taxotere in February 2008. The regimen with Taxotere continued through April 2008. She ultimately filed a permanent Alopecia lawsuit after her hair loss continued following the conclusion of treatment.

During treatment with Taxotere, Linda lost the hair on her scalp, eyebrows, eyelashes, and elsewhere. This is one of the more well-known side effects of chemotherapy, and most patients go into chemo understanding the risk of hair loss, or alopecia.

However, what patients generally don’t expect that the hair loss will be permanent. Instead, patients expect that the hair lost during treatment will begin to grow back after the chemo is over.

This was not Linda’s experience, nor that of countless other cancer patients like her. According to her permanent alopecia lawsuit, Linda’s hair loss has lasted for years following the end of her cancer treatment—even now, nearly ten full years later, Linda has not grown back the hair lost years ago. These side effects have also led to economic damages, emotional distress, psychological counseling, and more, the lawsuit claims.

Linda filed her permanent alopecia lawsuit on multiple counts, including failure to warn, negligence, fraudulent misrepresentation and concealment, and several others. The permanent alopecia lawsuit in early 2018 in the U.S. District Court for the Eastern District of Louisiana.

Basics of Taxotere

Taxotere (also sold as docetaxel, its generic name) is manufactured and sold by Sanofi. Taxotere is one of the most popular breast cancer treatment drugs and is also used for other cancer treatment, including lung cancer. Taxotere was approved by the U.S. Food and Drug Administration (FDA) back in 1996. Since then, Taxotere has grown increasingly more popular across the country.

So how does Taxotere work? In order to stop cancer cells from spreading quickly, Taxotere prevents cancer cells from growing. Taxotere fights cancer by preventing cancer cells from growing.

However, the same function that prevents the rapid growth of cancer cells may also prevent a patient’s hair from growing back after chemotherapy, causing Taxotere permanent hair loss problems.

Filing a Taxotere Permanent Alopecia Lawsuit

After experiencing Taxotere alopecia, a growing number of cancer patients like Linda have filed lawsuits against the drug’s manufacturers. According to this Taxotere permanent alopecia lawsuit and others like it, Sanofi either knew or should have known that Taxotere was linked with the risk of permanent hair loss.

If you or someone you love has suffered from serious side effects of Taxotere including alopecia, or permanent hair loss after cancer treatment, you may be able to gain some kind of financial compensation by filing a Taxotere permanent alopecia lawsuit.

Filing a Taxotere permanent hair loss lawsuit cannot take away the pain and suffering a cancer patient endures, or take away the effects of alopecia, but it can help compensate for the financial expenses incurred by cancer treatment bills or even lost wages.

The Permanent Alopecia Lawsuit is Case No. 2:18-cv-01252-KDE-MBN, in the U.S. District Court for the Eastern District of Louisiana.